Second cancers in patients with Chronic Lymphocytic Leukemia who received frontline FCR therapy – Distribution and clinical outcomes

Patients with Chronic Lymphocytic Leukemia (CLL) are known to have an increased incidence of second cancers, but the contribution of commonly used frontline therapies to the incidence of second cancers is unclear. We report on the characteristics, incidence, outcomes and factors associated with seco...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Leuk Lymphoma
Main Authors: Benjamini, Ohad, Jain, Preetesh, Trinh, Long, Qiao, Wei, Strom, Sara S., Lerner, Susan, Wang, Xuemei, Burger, Jan, Ferrajoli, Alessandra, Kantarjian, Hagop, O’Brien, Susan, Wierda, William, Estrov, Zeev, Keating, Michael
Formato: Artigo
Idioma:Inglês
Publicado: 2014
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4437921/
https://ncbi.nlm.nih.gov/pubmed/25308294
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/10428194.2014.957203
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares